Total Hip Arthroplasty Instability and Lumbo-pelvic Kinematics: EOS Imaging Assessment of Variation in Spinal and Pelvic Parameters From Standing to Sitting (HIPEOS)

The authors hypothesize that a pelvic kinematic disorder, demonstrated by a significant decrease in sacral slope, is associated with the risk of instability of total hip prosthesis, the sacral slope being measured by an EOS imaging system during the transition to sitting in unstable patients versus patients with no history of instability.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • CHU Lapeyronie de Montpellier
      • Nîmes, France, 30029
        • CHU Nîmes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient must be at least 18 years old and less than 85 years old
  • Patient has a conventional first intention total hip arthroplasty (not dual mobility) by posterior approach
  • "Case" patients have at least one previous episode of prosthetic dislocation repaired with surgery
  • "Control" patients have no previous episode of prosthetic dislocation with more than 2 year since initial intervention

Exclusion Criteria:

  • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patient is pregnant, parturient or breastfeeding
  • Patient with lumbar instrumentation
  • Patient with severe dementia (Mini Mental State Examination < 10)
  • Patient with American Society of Anesthesiologists score ≥ 4
  • Patient experience multiple falls
  • Patient requiring early revision surgery (<15 days postoperatively
  • Patient with obvious implant positioning error on an X-ray of the pelvis.
  • Patient with dislocation of traumatic origin (significant kinetic trauma)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Patients with previous prothesis instability
Whole body EOS imaging in seated and standing position
Other: Patients without prothesis instability
Whole body EOS imaging in seated and standing position

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sacral slope between standing to sitting difference between groups
Time Frame: Day 0
Sacral slope between standing to sitting difference between groups
Day 0
Rate of type 1 pelvic kinematic disorder between groups
Time Frame: Day 0
Measured by sacral slope difference from standing to seated position < 12°.
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lumbar lordosis between standing and seating between groups
Time Frame: Day 0
degree
Day 0
Femoroacetabular flexion between standing and seating between groups
Time Frame: Day 0
degree
Day 0
Lewinnek plane (Anterior pelvic plane) between standing and seating between groups
Time Frame: Day 0
degree
Day 0
Pelvic version between standing and seating between groups
Time Frame: Day 0
degree
Day 0
Classification of patients' pelvic kinematic disorder (Type 1 or 2)
Time Frame: Day 0
Type 1 = Difference in sacral slope between standing and seated position < 12° Type 2 = pelvic version < 20° standing
Day 0
Classification of patients according to pelvic incidence
Time Frame: Day 0
Presence/absence
Day 0
Classification of patients according to sacral slope
Time Frame: Day 0
Presence/absence
Day 0
Classification of patients according to sagittal imbalance
Time Frame: Day 0
Presence/absence of: Sagittal Vertical Axis > 50 mm; Spino-Sacral Angle < 127°
Day 0
Evolution of acetabular positioning (anteversion and inclination in degree) from standing to sitting
Time Frame: Day 0
Degree
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pascal Kouyoumdjian, MD, CHU Nîmes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 6, 2018

Primary Completion (Actual)

February 1, 2019

Study Completion (Actual)

February 1, 2019

Study Registration Dates

First Submitted

July 2, 2018

First Submitted That Met QC Criteria

July 19, 2018

First Posted (Actual)

July 27, 2018

Study Record Updates

Last Update Posted (Actual)

August 4, 2020

Last Update Submitted That Met QC Criteria

August 3, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • AOIGCSMERRI/2017/PK-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on EOS imagery

Subscribe